There is no single “best” birth control pill for ovarian cysts because the answer depends entirely on what you’re trying to accomplish and what type of cyst you’re dealing with. If you already have a functional ovarian cyst, the honest answer is that no pill will make it go away faster. If you’re trying to prevent new functional cysts from forming, older-style monophasic combined pills with higher estrogen doses offer the strongest protection, though the popular low-dose pills prescribed today provide far less. And if you’re managing endometriosis-related cysts or polycystic ovary syndrome, the calculus changes again. The gap between what many people believe about birth control and cysts and what the evidence actually shows is wider than you’d expect.
The Distinction That Changes Everything
Most people searching for the “best pill for ovarian cysts” assume the pill will shrink or dissolve a cyst they already have. This is the single most important misconception to clear up. A Cochrane systematic review pooling data from eight randomized trials across four countries found that combined oral contraceptives did not speed up the resolution of functional ovarian cysts in any trial, whether those cysts arose on their own or developed after fertility treatments.
Most functional cysts, the fluid-filled sacs that form during a normal menstrual cycle, resolve on their own within two or three cycles. Cysts that stick around longer tend to be pathological rather than physiological, meaning they’re things like endometriomas or paraovarian cysts that won’t respond to hormonal suppression the way a simple follicular or corpus luteum cyst would.1PubMed Central. Oral contraceptives for functional ovarian cysts So if your doctor put you on the pill specifically to treat an existing functional cyst, the evidence suggests watchful waiting would have worked just as well.2PubMed. Treatment of clomiphene citrate-related ovarian cysts in a prospective randomized study. A single center experience
This practice became widespread in the early 1970s. Because early oral contraceptives with high hormone doses were associated with fewer functional cysts, clinicians assumed the pills could also treat cysts that had already formed. That inference turned out to be wrong, but the habit persisted for decades.3Cochrane Database of Systematic Reviews. Oral contraceptives for functional ovarian cysts
Where the pill does matter is prevention. If you’ve had recurring functional cysts and want to reduce the likelihood of new ones forming, the type and dose of pill you choose makes a real difference.
Which Pills Prevent Functional Cysts Most Effectively
Not all combined pills suppress ovarian activity to the same degree, and that’s what determines whether they prevent cysts. The key variable is how thoroughly a pill quiets the ovaries. Older high-dose monophasic pills, those containing more than 35 micrograms of ethinyl estradiol with a steady daily dose, offered the most protection. One study found that high-dose monophasic pills reduced the rate of functional cysts to roughly a quarter of the rate seen in non-users. Low-dose monophasic pills (35 micrograms or less) cut the rate roughly in half, while multiphasic pills, which vary the hormone dose across the cycle, barely reduced the rate at all.4PubMed. Oral contraceptive type and functional ovarian cysts
A separate study comparing monophasic and triphasic formulations found a similar pattern: monophasic pills modestly lowered the risk while triphasic pills showed no meaningful reduction compared to using no hormonal contraception at all.5PubMed. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives The bottom line from reviews of these findings is that the protective effect seen with earlier high-dose pills may be weakened or lost with today’s low-dose formulations.6PubMed. Oral contraceptive use and benign gynecologic conditions. A review
This creates a practical tension. Modern pills were developed with lower hormone doses specifically to reduce side effects like headaches, bloating, breast tenderness, and clot risk. But those lower doses also mean less ovarian suppression, which means less cyst prevention. If preventing functional cysts is your primary reason for taking the pill, a monophasic pill at the higher end of the dose range is the better choice over a triphasic or ultra-low-dose formulation. But your provider will weigh that against your overall health picture.
Does the Estrogen Dose in Low-Dose Pills Matter
You might wonder whether going from 35 micrograms down to 20 micrograms of ethinyl estradiol, the jump that defines many of today’s “ultra-low-dose” pills, makes cysts more likely. At least one study comparing the two found that the 20-microgram pill didn’t lead to more follicles or cysts than the 35-microgram pill, possibly because the progestin component also plays a role in suppression.7Contraception. Ovarian function during low-dose oral contraceptive use So within the range of combined pills available today, the specific progestin paired with the estrogen matters alongside the estrogen dose itself. A strong progestin like levonorgestrel or desogestrel in a monophasic formulation may compensate for a somewhat lower estrogen level.
Where the evidence does line up is in the broader pattern: the further you move from high-dose, steady-state ovarian suppression, the less cyst prevention you get. The exact threshold isn’t perfectly defined, but monophasic formulations consistently outperform multiphasic ones, and higher estrogen doses consistently outperform lower ones when the progestin component is held constant.
Why Progestin-Only Pills Can Make Cysts Worse
If combined pills reduce or at least don’t increase functional cyst risk, progestin-only pills do the opposite. These pills, sometimes called the minipill, suppress one ovarian signal while leaving another partially intact, and the result is that follicles start growing but don’t always complete their cycle. They can stall and balloon into functional cysts instead.
Studies using ultrasound monitoring found functional cysts in roughly 40% of progestin-only pill users on initial scanning, with about 70% of women who failed to ovulate also developing a cyst. Among matched controls not using hormonal contraception, the cyst rate was around 19%, significantly lower.8PubMed. Studies on ovarian function in users of the progestagen only contraceptive pill Another ultrasound study confirmed that cysts with diameters up to 58 mm appeared in more than a third of minipill users, and some of these cysts were associated with pain.9PubMed. Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception
The cysts that develop on progestin-only pills are almost always benign and tend to resolve on their own, but they can cause discomfort and anxiety, especially if you’ve already been dealing with cyst-related symptoms. If you’re prone to functional cysts and are choosing a pill partly for cyst prevention, a progestin-only pill is likely the wrong choice. However, the picture is different for other progestin-only methods; an updated systematic review found that progestin-only pills, levonorgestrel IUDs, and implants did not carry elevated blood clot risk the way some other formulations do, making them appealing for women who can’t take estrogen.10PubMed Central. Progestin-only contraception and thrombosis: An updated systematic review The trade-off is real: safer from a clot standpoint, but potentially worse for cysts.
Endometriomas Are a Different Situation
Functional cysts, the kind formed during normal ovulation, account for about a third of all ovarian cysts. But if you have endometriosis, you may develop endometriomas, sometimes called chocolate cysts, which are filled with old blood and endometrial tissue. These don’t behave like functional cysts and don’t resolve the same way.
Combined oral contraceptives can reduce the size and pain associated with endometriomas. A retrospective study found that women using oral contraceptives had significantly smaller endometriomas and lower pain scores at both three and six months compared to non-users.11PubMed Central. Impact of oral contraceptive treatment duration on ovarian reserve markers and pain in women with ovarian endometrioma: a retrospective cohort study Dienogest, a progestin used in some combined pills and also as a standalone treatment, has shown promise in shrinking endometriomas when combined with aspiration, with continued reduction over 12 months.12PubMed Central. Exploring the Impact of Endometrioma Aspiration and Dienogest Combination Therapy on Cyst Size, Inflammatory Cytokines in Follicular Fluid and Fertility Outcomes
For endometriomas, then, the pill genuinely can be part of the treatment, not just prevention. This is one area where the advice “take the pill for your cyst” holds up, though your doctor may also consider surgery or GnRH agonists depending on the cyst size and your fertility goals.
PCOS and Choosing a Pill
Polycystic ovary syndrome adds another layer. The small follicles visible on ultrasound in PCOS aren’t the same as functional cysts. They’re partially developed follicles that accumulate because of hormonal imbalances, and the goals of treatment are broader: restoring regular periods, reducing excess androgen effects like acne and unwanted hair, and lowering long-term risks like endometrial cancer from chronic anovulation.
Combined oral contraceptives, along with lifestyle changes, are the first-line medical treatment for long-term PCOS management. They restore menstrual regularity, improve signs of excess androgen, and provide a protective effect on the uterine lining.13PubMed Central. An Update on Contraception in Polycystic Ovary Syndrome When picking a pill for PCOS specifically, providers often favor formulations with anti-androgenic progestins, since reducing androgen effects is a central treatment goal. Drospirenone, the progestin in brands like Yaz and Yasmin, is one such option that has shown benefit in the PCOS population.14PubMed Central. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome Cyproterone acetate, available in some countries but not the United States, is another anti-androgenic progestin sometimes used.
For PCOS, the “best” pill is one that addresses the full syndrome, not one optimized purely for ovarian suppression. A pill with drospirenone or a similar anti-androgenic progestin at a low estrogen dose is a common and well-supported choice, even though it may not suppress ovarian follicular activity as aggressively as a high-dose monophasic pill would.
Blood Clot Risk Varies by Formulation
Any combined pill increases blood clot risk to some degree, but the magnitude differs across progestin types. A systematic review found that pills containing levonorgestrel increased the risk of venous thrombosis by roughly three to four times over baseline, while formulations with newer progestins like desogestrel, gestodene, or drospirenone carried higher risks, ranging from about four times upward.15PubMed Central. Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis Absolute risk remains low for most women, but it’s relevant to the “best pill” question because the pill that’s best for cyst prevention (a higher-dose monophasic with a potent progestin) can also carry more thrombotic risk.
For women who cannot take estrogen at all, whether because of a history of blood clots, migraines with aura, or other risk factors, progestin-only options are generally preferred from a safety standpoint.16PubMed Central. Special Considerations for Women of Reproductive Age on Anticoagulation As covered earlier, progestin-only pills may increase functional cyst risk, so these women face a genuine trade-off. A levonorgestrel IUD, which delivers progestin locally and has minimal systemic hormonal effects, may be a reasonable middle ground. It provides contraception without the cyst-promoting effects seen with systemic progestin-only pills and avoids the clot risk of combined formulations.
Body Weight and Pill Performance
If you’re in a higher weight range, it’s worth knowing that obesity can alter how hormonal contraceptives are absorbed and metabolized. Some research has found changed drug levels and increased failure rates with combined pills, the contraceptive patch, and emergency contraceptive pills in women with obesity.17PubMed Central. Obesity and hormonal contraceptive efficacy Whether this translates to reduced cyst prevention specifically hasn’t been well studied, but if ovarian suppression is the mechanism that prevents cysts and drug levels are lower, it’s biologically plausible that protection could be diminished. This is another reason to discuss your full health picture with your provider when choosing a formulation.
When You Probably Don’t Need a Pill at All
Guidelines for managing benign ovarian masses generally recommend that asymptomatic cysts characterized as benign on ultrasound be followed with a repeat scan in 8 to 12 weeks. Masses that remain stable and don’t develop worrying features can then be monitored yearly. Most benign masses under 10 centimeters can be managed conservatively, meaning no surgery and no medication.18Journal of Obstetrics and Gynaecology Canada. Initial Investigation and Management of Benign Ovarian Masses
If you’ve been told you have a simple functional cyst with no concerning features, the most evidence-based approach is often to wait. The cyst will likely resolve on its own within a cycle or two. Starting or switching to a birth control pill to treat that specific cyst won’t speed things up. However, if functional cysts keep recurring and are causing you symptoms or anxiety, that’s when a conversation about ongoing pill use for prevention becomes worthwhile.
What Happens When You Stop the Pill
One thing that rarely comes up in discussions about the pill and cysts is what happens when you discontinue. The protective effect against functional cysts appears to be tied to current or very recent use. A large study found that women who had recently taken combined oral contraceptives, within the six months before diagnosis, had substantially fewer functional cysts than women who had never used them or had used them in the more distant past. The reduction was more pronounced for corpus luteum cysts (about 78%) than for follicular cysts (about 49%). But women who had used oral contraceptives previously and then stopped did not retain that protection.19BMJ. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives
This means the pill works like an umbrella: it protects you while you’re using it, but as soon as you put it away, you’re exposed again. If you’ve been on the pill for years and then stop, your ovaries resume their normal activity, and the possibility of functional cysts returns. The same study estimated that roughly 28 surgeries for functional cysts are avoided per 100,000 women taking oral contraceptives each year, a modest but meaningful number at a population level.
The Role of the Pill Before Fertility Treatments
One niche area where the pill’s cyst-prevention ability has clear clinical value is in preparation for assisted reproduction. Women undergoing IVF or similar treatments are sometimes given a GnRH agonist to suppress the ovaries before stimulation begins, and this process can itself trigger functional cyst formation. A study comparing women pretreated with oral contraceptives to those who weren’t found cysts in over half of the untreated group but in none of the pretreated group. The women who took oral contraceptives first also reached ovarian suppression faster, and their subsequent pregnancy rates were comparable.20PubMed Central. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues If you’re heading into a fertility cycle, your reproductive endocrinologist may prescribe a brief course of the pill for exactly this reason, and that’s one context where the evidence for using the pill to manage cyst risk is strong and specific.